all stories tagged «Biopharma».
stories appear here with a 15-minute delay. in real time — via the api connect the api →
6 stories
Liquidia stock rose almost 40% before the bell after a $381 million deal with United Therapeutics that resolves six lawsuits over its lung drug Yutrepia.
1 source · Newsmetry API
Cantor Fitzgerald reiterated Overweight on Omeros with a $22 target and Sterling Infrastructure with a $742 target. Reference data from Benzinga.
3 sources · Newsmetry API
Needham reiterated its Buy rating on Liquidia shares with a $58 price target. Analysts point to the outlook for Yutrepia and the settlement with United Therapeutics.
2 sources · Newsmetry API
Verastem has named Michael Bailey its president and CEO, effective January 1, 2027. Daniel Paterson is retiring from the top job but will stay on the board.
2 sources · Newsmetry API
HC Wainwright & Co. kept its Buy rating on Biomea Fusion with a $4.00 price target, citing OPAL study progress and Phase 1 data for BMF-650.
3 sources · Newsmetry API
BTIG reiterated its Buy rating on Domino's Pizza with a $425 price target, citing recovering franchisee economics and strong digital and marketing positions.
2 sources · Newsmetry API